JP2024529425A5 - - Google Patents

Info

Publication number
JP2024529425A5
JP2024529425A5 JP2024504461A JP2024504461A JP2024529425A5 JP 2024529425 A5 JP2024529425 A5 JP 2024529425A5 JP 2024504461 A JP2024504461 A JP 2024504461A JP 2024504461 A JP2024504461 A JP 2024504461A JP 2024529425 A5 JP2024529425 A5 JP 2024529425A5
Authority
JP
Japan
Application number
JP2024504461A
Other languages
Japanese (ja)
Other versions
JP2024529425A (ja
JPWO2023004409A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074041 external-priority patent/WO2023004409A1/en
Publication of JP2024529425A publication Critical patent/JP2024529425A/ja
Publication of JPWO2023004409A5 publication Critical patent/JPWO2023004409A5/ja
Publication of JP2024529425A5 publication Critical patent/JP2024529425A5/ja
Pending legal-status Critical Current

Links

JP2024504461A 2021-07-23 2022-07-22 CRISPR/Cas編集系のためのガイドRNA Pending JP2024529425A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163225322P 2021-07-23 2021-07-23
US63/225,322 2021-07-23
US202163255927P 2021-10-14 2021-10-14
US63/255,927 2021-10-14
PCT/US2022/074041 WO2023004409A1 (en) 2021-07-23 2022-07-22 Guide rnas for crispr/cas editing systems

Publications (3)

Publication Number Publication Date
JP2024529425A JP2024529425A (ja) 2024-08-06
JPWO2023004409A5 JPWO2023004409A5 (https=) 2025-07-18
JP2024529425A5 true JP2024529425A5 (https=) 2025-07-18

Family

ID=83149172

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504461A Pending JP2024529425A (ja) 2021-07-23 2022-07-22 CRISPR/Cas編集系のためのガイドRNA

Country Status (7)

Country Link
US (1) US20240301405A1 (https=)
EP (1) EP4373931A1 (https=)
JP (1) JP2024529425A (https=)
KR (1) KR20240037299A (https=)
AU (1) AU2022313315A1 (https=)
CA (1) CA3226664A1 (https=)
WO (1) WO2023004409A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230383277A1 (en) * 2020-10-14 2023-11-30 Beam Therapeutics Inc. Compositions and methods for treating glycogen storage disease type 1a
WO2024220980A2 (en) * 2023-04-20 2024-10-24 The Schepens Eye Research Institute, Inc. Dscam inhibitory nucleic acids and methods of use thereof
IL324634A (en) 2023-05-15 2026-01-01 Nchroma Bio Inc Compositions and methods for epigenetic regulation of hbv gene expression
WO2025087411A1 (zh) * 2023-10-25 2025-05-01 尧唐(上海)生物科技有限公司 一种脱氨酶、包含其的碱基编辑器及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4921757A (en) 1985-04-26 1990-05-01 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
JPH0825869B2 (ja) 1987-02-09 1996-03-13 株式会社ビタミン研究所 抗腫瘍剤包埋リポソ−ム製剤
US4911928A (en) 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US4917951A (en) 1987-07-28 1990-04-17 Micro-Pak, Inc. Lipid vesicles formed of surfactants and steroids
US5846946A (en) 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
JP4772045B2 (ja) 2004-07-16 2011-09-14 アメリカ合衆国 Cmv/r核酸コンストラクトを含むaidsに対するワクチン
WO2009088786A1 (en) 2007-12-31 2009-07-16 Nanocor Therapeutics, Inc. Rna interference for the treatment of heart failure
EP3241902B1 (en) 2012-05-25 2018-02-28 The Regents of The University of California Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
CN105139759B (zh) 2015-09-18 2017-10-10 京东方科技集团股份有限公司 一种拼接屏
WO2017058751A1 (en) * 2015-09-28 2017-04-06 North Carolina State University Methods and compositions for sequence specific antimicrobials
JP7109784B2 (ja) 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ 遺伝子編集のための進化したCas9蛋白質
KR102547316B1 (ko) 2016-08-03 2023-06-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
EP3829597A4 (en) * 2018-07-30 2022-05-18 Sarepta Therapeutics, Inc. TRIMER PEPTIDES FOR ANTISENSE ADMINISTRATION
JP2020038883A (ja) 2018-09-03 2020-03-12 株式会社オートネットワーク技術研究所 回路構造体及び回路構造体の製造方法
AU2020352931A1 (en) * 2019-09-23 2022-03-31 Flagship Pioneering Innovations V, Inc. Modulating genomic complexes
US20230020092A1 (en) * 2019-12-19 2023-01-19 Entrada Therapeutics, Inc. Compositions for delivery of antisense compounds

Similar Documents

Publication Publication Date Title
JP2024529425A5 (https=)
BR102022025291A2 (https=)
CL2025003982A1 (es) Pieza de molde y estación de moldeo
CL2025003836A1 (es) Método y sistema de agrupamiento de datos de un conjunto de datos
BR102023001877A2 (https=)
BR102022023461A2 (https=)
BY13176U (https=)
BY13172U (https=)
CN307049831S (https=)
CN307049173S (https=)
CN307048965S (https=)
CN307048510S (https=)
CN307048124S (https=)
CN307047848S (https=)
CN307046417S (https=)
CN307046061S (https=)
BY13162U (https=)
CN307045818S (https=)
CN307045175S (https=)
CN307044875S (https=)
CN307044760S (https=)
CN307044536S (https=)
BY23965C1 (https=)
BY23963C1 (https=)
BY13153U (https=)